LIFR and breast carcinoma: The preceding analysis suggests a transcriptomic pattern downstream of FAM3C/LIFR/STAT3 modulation that is specifically implicated in mammary carcinoma pathology and that is exemplified by changes in the regulation of an established mediator of EMT and cell fate, TWIST1.